Parks Laura L. 4
4 · Recro Pharma, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Parks Laura L.
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-14+20,000→ 20,000 totalExercise: $2.23Exp: 2031-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option will vest in three equal annual installments, beginning on June 14, 2022, subject to the Reporting Person's continuous service with the Company.